Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib

ZONG-HAN YAOWEI-YU LIAOCHAO-CHI HOKUAN-YU CHENJIN-YUAN SHIHJIN-SHING CHENZHONG-ZHE LINChia-Chi LinCHIH-HSIN YANGCHONG-JEN YU2022-09-152022-09-1520171083-7159https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029699677&doi=10.1634%2ftheoncologist.2016-0331&partnerID=40&md5=9e43d2571b88aa3797e7aabd7b416766https://scholars.lib.ntu.edu.tw/handle/123456789/620280[SDGs]SDG3Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinibjournal article10.1634/theoncologist.2016-0331285072062-s2.0-85029699677